PraneethChebroluMDMSCR

Clinical Trials

• Dendritic Cell Cancer Vaccine for High-grade Glioma Start of enrollment: 2010 Apr 01

  Completed

  Phase 2

• A Phase 3 Study of Tanezumab for Chronic Low Back Pain Start of enrollment: 2015 Aug 18

  Completed

  Phase 3

• An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation Start of enrollment: 2015 Dec 30

  Active, not recruiting

  Phase 3

• Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee Start of enrollment: 2016 Jan 21

  Completed

  Phase 3

• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy Start of enrollment: 2017 Dec 08

  Completed

  Phase 3

• Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation Start of enrollment: 2023 Aug 14

  Recruiting

  Phase 2

• Tumor Electric Fields Treatment System for Glioblastoma Start of enrollment: 2020 Apr 07

  Recruiting

  Early Phase 1

• A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer Start of enrollment: 2020 Jul 09

  Completed

  Phase 1

• Join now to see all